EGFR and endometrial cancer: With CD44 playing as an auxiliary receptor in promoting growth factor receptor activities [15, 16], this explains how NMU signaling also tightly controls the intensity of EGFR-driven and TGFβ receptor-driven EMT in endometrial cancer cells.